http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-248282-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62b563909ed77d94afc3c237e0fbd935
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
filingDate 1984-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ec8461b4662da6fdd3ae198e20e4c16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a24c65470a0c483e4fa224cf11bb665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a99f7417d5dca186ee1547ef0f3dd20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fcae41a16768044780dc8d0381e1cf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34cf139f571ccaaa2ca3906ed7fe73b
publicationDate 1987-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-248282-A1
titleOfInvention MEANS FOR THE TREATMENT OF SKIN DISEASES AND TUMORS
abstract The object of the invention is the development of a process for the preparation of a medicament for the treatment of skin diseases, in particular of psoriasis, as well as for the treatment of various tumors. According to the invention, pharmaceutical preparations which contain phaeophorbide a or its pharmaceutically acceptable salts or a mixture of these substances as active substance, if appropriate together with excipients or carriers, are converted into a suitable administration form.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1834955-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5492924-A
priorityDate 1984-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433298372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154438332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID253193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433567920

Total number of triples: 36.